ROPIVACAINE HYDROCHLORIDE
NDC 43066-019, ropivacaine hydrochloride, injection, from Baxter Healthcare Corporation.
- Product NDC
- 43066-019
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION
- Route
- EPIDURAL, INFILTRATION, PERINEURAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212808
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43066-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROPIVACAINE HYDROCHLORIDE5 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43066-019-10 | 43066001910 | 10 VIAL in 1 CARTON (43066-019-10) / 20 mL in 1 VIAL (43066-019-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/781d4b7f-7556-4695-8d48-7772d7a0d8e9Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=43066-019
Use it
Look up 43066-019 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43066-019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43066-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.